Lupin receives USFDA approval for Albendazole Tablets USP
Lupin receives USFDA approval for Albendazole Tablets USP

Lupin receives USFDA approval for Albendazole Tablets USP

DSIJ Intelligence Article rating: 3.9

Thursday brought with it an announcement from pharma company, Lupin Limited stating that it had been granted approval by United States Food and Drug Administration (USFDA) for Albendazole Tablets USP, 200 mg.

Wipro partners with CloudKnox Security, enhancing cloud security
Wipro partners with CloudKnox Security, enhancing cloud security

Wipro partners with CloudKnox Security, enhancing cloud security

DSIJ Intelligence Article rating: 5.0

IT company, Wipro Limited declared its tie-up with CloudKnox Security, a cybersecurity start-up, to enable enterprises to proactively safeguard and manage their hybrid and multi-cloud infrastructure by detecting and remediating over-permissioned identities.

Protect your capital first!
Protect your capital first!

Protect your capital first!

DSIJ Intelligence Article rating: 4.4

There is a high correlation between downward protection and long-term outperformance. This is because protecting from losses in the falling markets leaves more capital to grow than when the market rises again.

Index trend and stocks in action on June 12, 2020
Index trend and stocks in action on June 12, 2020

Index trend and stocks in action on June 12, 2020

DSIJ Intelligence-3 Article rating: 4.0

Nifty has witnessed a distribution day as it ended with sharp losses on the back of higher volume as compared to its prior session. Traders are advised not to venture into aggressive long position as long as the index stays below this level. Stocks in news: Biocon, SBI Life Insurance, Wipro, Lupin. 

Sensex tumbles by over 700 points, Vodafone Idea dips by 13 per cent
Sensex tumbles by over 700 points, Vodafone Idea dips by 13 per cent

Sensex tumbles by over 700 points, Vodafone Idea dips by 13 per cent

DSIJ Intelligence Article rating: 3.8

Today's trading session ended on a negative note with domestic benchmark indices absorbing cues from global stocks and US Fed's policy announcement. Sensex tanked by 708.68 points or 2.07 per cent to settle at 33,538.37 while Nifty dropped by 214.15 points or 2.12 per cent and fell below its 10k levels settling at the level of 9,902 on Thursday.

S&P Global Ratings holds India rating at BBB- with stable outlook
S&P Global Ratings holds India rating at BBB- with stable outlook

S&P Global Ratings holds India rating at BBB- with stable outlook

Nidhi Jani Article rating: 5.0

The agency said it foresees India making a strong recovery after the anticipated deep contraction in FY21, with GDP growth at 8.5 per cent in FY22. As per its predictions, India's economy will shrink by 5 per cent this fiscal.

FOMC maintains fed funds rate near zero
FOMC maintains fed funds rate near zero

FOMC maintains fed funds rate near zero

Amir Shaikh Article rating: 5.0

On Wednesday in line with market expectation Federal Open Market Committee (FOMC) voted unanimously to keep the fed funds rate in a range of zero per cent to 0.25 per cent

RSS
First28922893289428952897289929002901Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR